Nurix Therapeutics Inc (NRIX) Ownership

12.09 ↓0.37 (-2.97%)
As of January 26, 2023, 3:59pm EST.

Institutional Ownership

Baker Bros Advisors LP is the biggest individual institutional holder of Nurix Therapeutics Inc (NRIX), owning a total of 3.9 million shares. Combined, the top 24 institutional holders of NRIX own 82.11% of the company with a total of 38.7 million shares.

In the latest ownership report on September 30th 2022, the top 24 institutional holders increased their combined ownership of NRIX by 1.1 million shares. 9 institutions bought 3,271,640 total additional shares and increased their ownership by an average of 36.63%. However 7 institutions sold 2,179,732 total shares and decreased their ownership by an average of 17.26%.

Overall this is a positive sign as the number of shares owned by the top 20 institutional holders of Nurix Therapeutics Inc increased by a net total of 1,091,908 in the latest quarter.

Institution Ownership Chart

Your browser does not support this chart.

Latest Institutional Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Baker Bros Advisors LP8.234%0.000%3,882,12502022-09-30
BlackRock Inc7.897%10.960%3,723,090367,7432022-09-30
T. Rowe Price Associates, Inc.7.649%-21.954%3,606,352-1,014,4712022-09-30
Redmile Group, LLC6.377%0.000%3,006,68402022-09-30
Wasatch Advisors Inc.5.636%17.427%2,657,437394,3742022-09-30
State Street Corporation4.904%9.234%2,312,224195,4532022-09-30
Vanguard Group Inc4.583%2.338%2,160,86649,3702022-09-30
Deep Track Capital, LP4.356%-15.703%2,053,621-382,5432022-09-30
Bain Capital Life Sciences Investors, LLC3.866%0.000%1,822,88302022-09-30
FMR Inc3.575%-5.864%1,685,651-105,0042022-09-30
ARK Investment Management LLC2.729%65.209%1,286,522507,7972022-09-30
Boxer Capital LLC2.598%0.000%1,224,89202022-09-30
T. Rowe Price Investment Management,Inc.2.105%0.000%992,428992,4282022-09-30
Candriam Luxembourg S.C.A.1.751%-1.644%825,575-13,8002022-09-30
Goldman Sachs Group Inc1.750%148.635%825,079493,2362022-09-30
Geode Capital Management, LLC1.732%5.582%816,46243,1682022-09-30
Millennium Management LLC1.569%-8.868%739,925-72,0032022-09-30
Dafna Capital Management LLC1.202%0.000%566,69502022-09-30
Nuveen Asset Management, LLC1.172%70.265%552,656228,0712022-09-30
Soleus Capital Management, L.P.1.069%-49.306%504,144-490,3482022-09-30
Morgan Stanley - Brokerage Accounts1.019%-17.448%480,542-101,5632022-09-30

Top Institutions

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Baker Bros Advisors LP8.234%0.000%3,882,12502022-09-30
BlackRock Inc7.897%10.960%3,723,090367,7432022-09-30
T. Rowe Price Associates, Inc.7.649%-21.954%3,606,352-1,014,4712022-09-30
Redmile Group, LLC6.377%0.000%3,006,68402022-09-30
Wasatch Advisors Inc.5.636%17.427%2,657,437394,3742022-09-30
State Street Corporation4.904%9.234%2,312,224195,4532022-09-30
Vanguard Group Inc4.583%2.338%2,160,86649,3702022-09-30
Deep Track Capital, LP4.356%-15.703%2,053,621-382,5432022-09-30
TRV GP III, LLC4.078%0.000%1,922,54902022-06-30
Bain Capital Life Sciences Investors, LLC3.866%0.000%1,822,88302022-09-30
FMR Inc3.575%-5.864%1,685,651-105,0042022-09-30
ARK Investment Management LLC2.729%65.209%1,286,522507,7972022-09-30
Boxer Capital LLC2.598%0.000%1,224,89202022-09-30
T. Rowe Price Investment Management,Inc.2.105%0.000%992,428992,4282022-09-30
Candriam Luxembourg S.C.A.1.751%-1.644%825,575-13,8002022-09-30
Goldman Sachs Group Inc1.750%148.635%825,079493,2362022-09-30
Geode Capital Management, LLC1.732%5.582%816,46243,1682022-09-30
Millennium Management LLC1.569%-8.868%739,925-72,0032022-09-30
Foresite Capital Management IV, LLC1.436%-34.309%677,143-353,6552022-06-30
Dafna Capital Management LLC1.202%0.000%566,69502022-09-30
Nuveen Asset Management, LLC1.172%70.265%552,656228,0712022-09-30
Soleus Capital Management, L.P.1.069%-49.306%504,144-490,3482022-09-30
Morgan Stanley - Brokerage Accounts1.019%-17.448%480,542-101,5632022-09-30
Northern Trust Corp0.823%27.470%388,19483,6572022-06-30

Mutual Fund Ownership

ARK Genomic Revolution ETF is the biggest individual fund holder of Nurix Therapeutics Inc (NRIX), owning a total of 2 million shares. Combined, the top 22 mutual fund holders of NRIX own 40.36% of the company with a total of 19 million shares.

In the latest ownership report on December 31st 2022, the top 22 fund holders increased their combined ownership of NRIX by 11 thousand shares. 1 funds bought 25,000 total additional shares and increased their ownership by an average of 5.98%. However 1 funds sold 13,906 total shares and decreased their ownership by an average of 0.87%.

Overall this is a positive sign as the number of shares owned by the top 20 mutual funds holding Nurix Therapeutics Inc increased by a net total of 11,094 in the latest report.

Mutual Funds Chart

Your browser does not support this chart.

Latest Mutual Fund Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
SPDR® S&P Biotech ETF3.351%-0.872%1,580,126-13,9062022-12-31
Belfius Equities Cure C Cap0.940%5.980%443,09625,0002022-12-31

Top Mutual Funds

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
ARK Genomic Revolution ETF4.247%0.074%2,002,3171,4782022-12-29
T. Rowe Price New Horizons4.106%-0.088%1,935,738-1,7052022-09-30
SPDR® S&P Biotech ETF3.351%-0.872%1,580,126-13,9062022-12-31
ARK Genomic Revolution2.709%68.551%1,277,262519,4732022-09-30
Vanguard Instl Ttl Stck Mkt Idx Tr2.575%2.259%1,214,14626,8212022-09-30
Vanguard Total Stock Mkt Idx Inv2.575%0.000%1,214,14602022-11-30
Eventide Healthcare & Life Sciences I2.448%-38.289%1,154,000-716,0002022-06-30
Fidelity® Select Biotechnology2.241%-32.999%1,056,746-520,4602022-11-30
iShares Russell 2000 ETF2.221%-0.829%1,047,082-8,7502022-12-30
Wasatch Small Cap Growth Investor1.767%18.566%833,208130,4702022-09-30
Pictet-Biotech P USD1.652%-1.892%778,719-15,0192022-06-30
UBS: US Equity Small Cap Growth1.250%0.000%589,17602022-09-30
Vanguard Extended Market Index Investor1.219%0.514%574,7132,9392022-11-30
Pictet-Global Megatrend Sel I USD1.039%-1.023%489,905-5,0632022-06-30
iShares Russell 2000 Value ETF1.029%0.000%484,95102022-12-30
Wasatch Ultra Growth0.973%0.000%458,64402022-09-30
Belfius Equities Cure C Cap0.940%5.980%443,09625,0002022-12-31
Candriam Global Equities Oncology0.887%0.000%418,09602022-09-30
T. Rowe Price Small-Cap Value0.828%-30.260%390,408-169,4002022-09-30
Fidelity® Small Cap Index0.787%4.315%371,04115,3482022-10-31
TIAA-CREF Quant Small-Cap Equity Instl0.762%0.000%359,09002022-10-31
Wasatch Small Cap Value0.751%37.047%353,92895,6742022-09-30

Discussions

Please log in or register to share your thoughts.

gangganggang

$NRIX the future is so bright .. I gotta wear shades..

0 Like Report
john_joes_mma

$NRIX damn lots of volume came after hours just now
what the?

0 Like Report
troubledelights

$NRIX buy and hodl friends. we may be early
but we are not wrong. very soon.

0 Like Report
delaina

$NRIX Love this stock.

Light taps

0 Like Report